Overview

A Cardiac Liability Study of Varegacestat in Healthy Participants

Status:
COMPLETED
Trial end date:
2025-05-06
Target enrollment:
Participant gender:
Summary
This clinical study is designed to study the effect of a single dose of varegacestat on cardiac repolarization in healthy adult participants.
Phase:
PHASE1
Details
Lead Sponsor:
Immunome, Inc.
Treatments:
Moxifloxacin